Richard Saitz

Yoga for Chronic Low-Back Pain

Many people practice yoga as a treatment for back pain, but, until now, its efficacy has not been proven in a clinical trial. Researchers in Washington

Smoking Cessation and Risk for Type 2 Diabetes

Smoking is a risk factor for developing type 2 diabetes. Smoking cessation clearly has many benefits, but subsequent weight gain can occur. Researchers evaluated type 2 diabetes risk that was associated with smoking and smoking cessation in a prospective population-based cohort of 10,892 adults (age range, 45–64; …

Adverse Drug Events in Older Adults

The Beers criteria are a consensus-based list of more than 40 medications or medication categories that are ineffective, unnecessarily risky, or

Geriatric “Conditions” as Common as Chronic Diseases

Geriatric “conditions” — for example, incontinence and cognitive impairment — include groups of signs and symptoms that are not necessarily related to

Serious Complications of Colonoscopy Are Not Rare

Because colonoscopy is a widely recommended screening test, precise population-based data on complications are important. To identify serious

Risk-Based Statin Treatment

The widely recommended “treat-to-target” strategy, which is the basis for the National Cholesterol Education Program (NCEP) guidelines, involves

Risk for Deep Venous Thrombosis in Patients with Superficial Venous Thrombosis

The role of anticoagulation in patients with superficial venous thrombosis is controversial, because their risk for deep venous thrombosis (DVT) or

When Primary Care Physicians and Specialists Communicate . . .

The effects of timely communication between primary care physicians (PCPs) and specialists on patient outcomes are uncertain. In a systematic

Pipe and Cigar Smoking Are Associated with Airflow Obstruction

The effect of pipe and cigar use on lung function is not well defined. Using a population-based sample selected from six U.S. communities,

Cardiovascular Benefit of Glycemic Control Is Limited to Those with Low Comorbidity

The effect of glycemic control on preventing adverse cardiovascular events has been difficult to demonstrate, possibly because such effects are limited